Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Till Milde

Showing results (91-100 of 161) with videos related to

Pageof 17
Sort By:
Neuro-Oncology|August 22, 2020
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastomaJonas Ecker, Venu Thatikonda, Gianluca Sigismondo, et al.
Cancers|February 15, 2022
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft ModelsCharlotte Gatzweiler, Johannes Ridinger, Sonja Herter, et al.
Acta Neuropathologica|December 2, 2022
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohortsMartin Mynarek, Denise Obrecht, Martin Sill, et al.
Acta Neuropathologica|April 5, 2016
Risk stratification of childhood medulloblastoma in the molecular era: the current consensusVijay Ramaswamy, Marc Remke, Eric Bouffet, et al.
Journal of Neuro-Oncology|May 14, 2023
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cellsGintvile Valinciute, Jonas Ecker, Florian Selt, et al.
Clinical Epigenetics|December 12, 2019
Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemiaCornelis M van Tilburg, Till Milde, Ruth Witt, et al.
Acta Neuropathologica|July 4, 2018
Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experienceDavid Capper, Damian Stichel, Felix Sahm, et al.
Neuro-Oncology|January 30, 2023
Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroupsSvenja Tonn, Andrey Korshunov, Denise Obrecht, et al.
Neuro-Oncology Advances|February 3, 2025
Pediatric spinal high-grade glioma in the pediatric precision oncology registry INFORM: Identification of potential therapeutic targetsElke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, et al.
Acta Neuropathologica|March 14, 2025
Constitutional variants in PTEN: a frequent finding in patients with papillary tumors of the pineal region subtype B (PTPR-B) associated with isolated loss of chromosome 10Steffen Hirsch, Ramin Rahmanzade, Kerstin Grund, et al.
Pageof 17

Showing results (91-100 of 161) with videos related to

Sort By:
Pageof 17
Neuro-Oncology|August 22, 2020
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastomaJonas Ecker, Venu Thatikonda, Gianluca Sigismondo, et al.
Cancers|February 15, 2022
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft ModelsCharlotte Gatzweiler, Johannes Ridinger, Sonja Herter, et al.
Acta Neuropathologica|December 2, 2022
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohortsMartin Mynarek, Denise Obrecht, Martin Sill, et al.
Acta Neuropathologica|April 5, 2016
Risk stratification of childhood medulloblastoma in the molecular era: the current consensusVijay Ramaswamy, Marc Remke, Eric Bouffet, et al.
Journal of Neuro-Oncology|May 14, 2023
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cellsGintvile Valinciute, Jonas Ecker, Florian Selt, et al.
Clinical Epigenetics|December 12, 2019
Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemiaCornelis M van Tilburg, Till Milde, Ruth Witt, et al.
Acta Neuropathologica|July 4, 2018
Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experienceDavid Capper, Damian Stichel, Felix Sahm, et al.
Neuro-Oncology|January 30, 2023
Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroupsSvenja Tonn, Andrey Korshunov, Denise Obrecht, et al.
Neuro-Oncology Advances|February 3, 2025
Pediatric spinal high-grade glioma in the pediatric precision oncology registry INFORM: Identification of potential therapeutic targetsElke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, et al.
Acta Neuropathologica|March 14, 2025
Constitutional variants in PTEN: a frequent finding in patients with papillary tumors of the pineal region subtype B (PTPR-B) associated with isolated loss of chromosome 10Steffen Hirsch, Ramin Rahmanzade, Kerstin Grund, et al.
Pageof 17